Biomarker

Visual and auditory evoked potentials showed promise as an objective measurement of Rett syndrome severity, according to a study published in Annals of Neurology.

Considerably fewer community oncology clinicians than academic clinicians use biomarker testing to guide discussions with patients with lung cancer, according to survey results.

David Carbone, MD, PhD, received International Association for the Study of Lung Cancer’s Paul A. Bunn Jr. Scientific Award.

Researchers identified biomarkers linked to work-related asthma among exposures present at workplaces, including flour, isocyanate and welding fumes, according to data published in Journal of Allergy and Clinical Immunology.

High-sensitivity cardiac troponin may be used as a marker for predicting coronary artery disease risk in patients with nonalcoholic fatty liver disease, according to a study published in Clinical Gastroenterology and Hepatology.

Precision medicine via genetic testing and family history can reduce uncertainty in diabetes diagnoses and allow more targeted therapy, improving patient-centered outcomes, such as mental health and quality of life, according to a speaker.

Applying different assessment measures impacted the results of two studies on the progression of chronic kidney disease in children. Alternate evaluation produced variability that altered the CKD conclusions, according to research.

A novel noninvasive droplet digital polymerase chain reaction-based assay predicted treatment response months before standard imaging scans among a cohort of patients with metastatic HPV-associated oropharynx squamous cell carcinoma.

National Comprehensive Cancer Network guidelines recommend all patients with advanced nonsquamous non-small cell lung cancer undergo biomarker testing.

In this video, Nathan A. Pennell, MD, PhD, highlighted a presentation from the virtual ASCO Annual Meeting, which looked at trends in molecular testing among patients with metastatic lung cancer in the U.S.